HCG Manavata Cancer Centre (HCG MCC) has launched its Hyperbaric Oxygen Therapy (HBOT) department, aimed at accelerating healing and enhancing recovery for patients. The advanced HBOT infrastructure at HCG MCC is designed to accommodate up to four patients simultaneously, offering a significant upgrade from traditional monoplace chambers.
The facility was inaugurated by prominent medical leaders, including Dr Sudhir Sanklecha, President of the Indian Medical Association, Nashik; Dr Rajendra Nehete, a renowned plastic surgeon; Dr Rupam Gangurde, a famous cosmetologist; Dr Mustafa Topiwala, a distinguished physiotherapist; and senior surgeons Dr Mahesh Malu, Dr Sachin Arsule, Dr Santosh Rawalani, and Dr Pramod Shinde.
Prof Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services at HCG MCC, stated, “This development extends our commitment to providing world-class care at HCG Manavata Cancer Centre. Our goal is to ensure patients have access to the best global healthcare standards. I extend heartfelt gratitude to everyone who supported this vision.”
HBOT offers several health benefits by delivering 100 per cent oxygen in a pressurised chamber, allowing the body to absorb higher levels of oxygen. Enhanced wound healing is one of the primary benefits, with HBOT promoting the faster healing of chronic wounds such as diabetic foot ulcers, while reducing swelling and inflammation. It also improves oxygen delivery, increasing oxygen levels in the blood and helping tissues deprived of oxygen due to injury, infection, or poor circulation.
The therapy supports brain health, aiding recovery from traumatic brain injuries (TBI), strokes, and neurological conditions. By enhancing oxygen supply to brain cells, HBOT helps improve cognitive function and reduce symptoms of conditions such as post-concussion syndrome. It also reduces infection risk, helping the body fight bacterial infections, including those caused by anaerobic bacteria. HBOT has shown effectiveness in treating conditions like gas gangrene and necrotising fasciitis.
Additionally, HBOT boosts stem cell production, stimulating the production of stem cells that aid in tissue repair and regeneration. It also enhances recovery from radiation therapy, helping manage the side effects of radiation-induced tissue damage by improving oxygenation and promoting repair.
HBOT can be beneficial for athletes, aiding in recovery from sports injuries by reducing inflammation and enhancing tissue repair. It is also essential for treating decompression sickness, or “the bends,” in divers by eliminating nitrogen bubbles from the bloodstream. Some studies suggest HBOT may offer anti-aging and skin benefits, improving skin health, reducing wrinkles, and enhancing collagen production by improving circulation and oxygenation. Furthermore, it may provide relief for chronic conditions such as fibromyalgia, chronic fatigue syndrome, and autoimmune disorders by reducing inflammation and improving cellular function.
“However, HBOT should always be administered under medical supervision, as improper use can lead to side effects such as oxygen toxicity or barotrauma,” states the press release.
Accredited with Digital Health Standards by the National Accreditation Board for Hospitals and Healthcare Providers (NABH), HCGMCC remains dedicated to advancing healthcare delivery through innovation and prioritising patient safety.